Sartorius Pref (SATG_p)

Currency in EUR
291.50
+0.50(+0.17%)
Closed·
SATG_p is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
288.90293.90
52 wk Range
198.50299.30
Key Statistics
Bid/Ask
290.50 / 291.50
Prev. Close
291
Open
290
Day's Range
288.9-293.9
52 wk Range
198.5-299.3
Volume
92.32K
Average Volume (3m)
99.89K
1-Year Change
27.7388%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SATG_p Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
297.50
Upside
+2.06%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period

Sartorius Pref News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Analyst Ratings

16 Buy
3 Hold
1 Sell
Ratings:
20 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 297.50
(+2.06% Upside)

Earnings

Latest Release
Oct 23, 2026
EPS / Forecast
1.27 / 1.25
Revenue / Forecast
926.3M / 895.89M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -
Dividend Yield
0.25%
Industry Median 1.72%
Annualized payout
0.74
Paid annually
5-Years Growth
+1.12%
Growth Streak

SATG_p Income Statement

Compare SATG_p to Peers and Sector

Metrics to compare
SATG_p
Peers
Sector
Relationship
P/E Ratio
81.4x33.4x−0.2x
PEG Ratio
-1.040.00
Price/Book
6.1x3.1x2.6x
Price / LTM Sales
4.9x5.2x2.7x
Upside (Analyst Target)
2.3%5.6%66.0%
Fair Value Upside
Unlock−0.7%10.8%Unlock

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Employees
14273
Market
Germany

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.92M15.82%3.18B
Other Institutional Investors
41.73M60.45%12.14B
Public Companies & Retail Investors
16.38M23.73%4.77B
Total
69.04M100.00%20.09B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Bio-Rad Laboratories, Inc.32.97%22,758,5086,622,726
Estate of Horst Sartorius27.28%18,831,2685,479,899

People Also Watch

324.200
DB1Gn
-1.61%
34.400
AFXG
-1.43%
94.960
SY1G
-1.10%
88.20
WLSNc
-2.91%
177.450
HEIG
+0.17%

FAQ

What Is the Sartorius Pref (SATG_p) Stock Price Today?

The Sartorius Pref stock price today is 291.50 EUR.

What Stock Exchange Does Sartorius Pref Trade On?

Sartorius Pref is listed and trades on the Frankfurt Stock Exchange.

What Is the Stock Symbol for Sartorius Pref?

The stock symbol for Sartorius Pref is "SATG_p."

Does Sartorius Pref Pay Dividends? What’s The Current Dividend Yield?

The Sartorius Pref dividend yield is 0.3%%.

What Is the Sartorius Pref Market Cap?

As of today, Sartorius Pref market cap is 15.60B EUR.

When Is the Next Sartorius Pref Earnings Date?

Sartorius Pref will release its next earnings report on Feb 23, 2027.

From a Technical Analysis Perspective, Is SATG_p a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Sartorius Pref Stock Split?

Sartorius Pref has split 1 times.

How Many Employees Does Sartorius Pref Have?

Sartorius Pref has 14273 employees.

What is the current trading status of Sartorius Pref (SATG_p)?

As of Nov 17, 2026, Sartorius Pref (SATG_p) is trading at a price of 291.50 EUR, with a previous close of 291.00 EUR. The stock has fluctuated within a day range of 288.90 EUR to 293.90 EUR, while its 52-week range spans from 198.50 EUR to 299.30 EUR.

What Is Sartorius Pref (SATG_p) Price Target According to Analysts?

The average 12-month price target for Sartorius Pref is 297.50 EUR, with a high estimate of 340 EUR and a low estimate of 200 EUR. 16 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Buy. The stock has an +2.06% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.